- Funds to support further development and commercialization of the Company’s INDUCE-seq DNA break mapping technology
- Platform technology provides in situ off-target measurement in clinically relevant cells to accelerate the progression of cell and gene therapy programs
- New investors include Illumina Ventures, Mérieux Equity Partners, and HERAN Partners
News
Recognising that research and development and production of medicines requires a significant amount of energy, AstraZeneca recently shared an article on 'Powering emissions reductions with clean heat and renewable energy' explaining how they are working toward net zero goals through innovative partnerships.
"The addition of the 1.25 millionth structure to the CSD is a great achievement for the community. Being the world’s largest database of small-molecule organic and metal-organic crystal structure data, the CSD is used in over 70 countries by scientists and crystallographers working both in academia and in pharmaceutical companies. Each of the structures deposited by scientists from around the globe is curated by our expert scientific editors prior to entry in the database.
After five years of leading LifeArc, Dr. Melanie Lee has informed the Board of her decision to step down as Chief Executive Officer.
We extend an invitation to explore our latest article titled "Powering Regional Growth: The Cambridge Cluster” penned by our CEO, Sunil Shah. The recent article which has been published by Intelligent Partnership delves into various facets of the biotech ecosystem, including insights on the golden triangle and tax-efficient investment strategies.
Should you find this content valuable, we would request you to share it with your professional network.
Register now for our free workshop! Express your Tech: communicating your complex innovation
Thursday 5 October 2023 | 3:00pm to 6:30pm | St John’s Innovation Centre, Cowley Road, Cambridge, CB4 0WS
You’ve spent years on research and product development, and now it’s time to take your product or service to market. But how do you sum it up in a sentence that excites investors? How do you put yourself in your customer’s shoes and pinpoint how your offer solves their problems? How do you tailor your message for the different channels and platforms?
Artificial Intelligence (AI) is changing the future of all industries, but findings published today by intellectual property firm, Marks & Clerk, reveal the medical technology (medtech) sector is surging ahead. The number of AI-based patent applications filed by the sector has almost quadrupled since 2018 to 2771 medtech publications in 2022. But most strikingly, as a standalone sector, the year-on-year percentage growth in the number of AI applications filed repeatedly surpassed that of overall AI between 2014 and 2021.
Alignment with
Innovative study design allows for potential accelerated approval in untreated (first-line) and previously treated (second-line plus) metastatic bladder cancer
Conference call and webcast today at
Zurich, Switzerland and Cambridge, UK, September 2023 – Biotechgate, a leading global life sciences business development and licensing database and One Nucleus, a Cambridge, UK-based life sciences and healthcare membership organisation, are thrilled to announce a collaboration to boost life sciences connectivity and innovation. The purpose of this collaboration is to provide a reliable hub of information for professionals, organizations, and individuals across the industry by enhancing connections and promoting innovation.
Huge congratulations to Dr Sally Ann Forsyth OBE, CEO, Stevenage Bioscience Catalyst, who has been awarded an Honorary Doctorate from the University of Hertfordshire in recognition of her lifetime achievements in science, on Tuesday 5 September at the start of the University of Hertfordshire’s annual graduation ceremony taking place over two weeks at St Albans Cathedral.